Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Association With Reduced Ischemic Stroke Risk
Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 2124-2134
DOI: 10.1002/ccd.70579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 01.04.2026. Verfasst von Omar Saleh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Eastern Virginia Medical School, Norfolk, …. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Pacemaker, Artificial, Ischemic Stroke, Cardiac Pacing, Artificial. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Development of conduction abnormalities requiring pacing after transcatheter aortic valve replacement (TAVR) is relatively common. The effects of post‐TAVR permanent pacemaker (PPM) implantation on mortality, ischemic stroke, and cardiovascular outcomes remain incompletely characterized.
Aims
To evaluate the incidence, predictors, and cardiovascular outcomes of post‐TAVR permanent pacemaker implantation, including its association with 1‐year ischemic stroke risk.
Methods
Adults undergoing TAVR (2008–2019; n = 1101) were evaluated. Patients with prior PPM ( n = 104) and/or valve‐in‐valve or redo TAVR ( n = 11) were excluded. PPM placement was identified post‐indexed TAVR admission based on procedure codes, including both in‐hospital and post‐discharge implantations. Primary outcomes included 1‐year mortality, major adverse cardiovascular events (MACE), myocardial infarction (MI), and ischemic stroke. Multivariate logistic regression was performed to identify independent predictors of 1‐year ischemic stroke.
Results
Within the TAVR cohort ( N = 1101), 158 patients (14.4%) received PPM within 1‐year, including 135 (12.3%) in‐hospital and 23 post‐discharge. PPM was not associated with a significant difference in 1‐year mortality (15.8% vs. 14.7%, p = 0.816) or 1‐year MACE (20.9% vs. 21.0%, p = 1.000). However, PPM was associated with significantly lower ischemic stroke rate at 1 year (1.3% vs. 4.8%, p = 0.044). In multivariate analysis adjusting for age, sex, and comorbidities, PPM was associated with 77% lower risk of 1‐year ischemic stroke (adjusted OR 0.234, 95% CI 0.056–0.977, p = 0.046). Late PPM implantation (> 3 days) was associated with numerically higher 1‐year mortality (30.0% vs. 14.3%, p = 0.647) and MACE (36.7% vs. 17.1%, p = 0.119) compared to early implantation, though these outcomes did not reach statistical significance.
Conclusion
PPM after TAVR was not associated with increased mortality or MACE but was independently associated with significantly lower ischemic stroke risk. Late PPM implantation showed a trend toward worse outcomes. These findings suggest that appropriately indicated PPM may confer cerebrovascular protection, and early implantation when indicated may be preferable. These findings warrant further validation in prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Eastern Virginia Medical School, Norfolk, Virginia, USA.
- Eastern Virginia Medical School, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia, USA.
- Department of Cardiology, University of Arizona, Tucson, Arizona, USA.
- Department of Structural Cardiology, Sentara Medical Group, Sentara Health, Virginia Beach, Virginia, USA.
ORCID-Profile: Omar Saleh, Nicholas J Valle
Zitieren
APA
Saleh, O., Valle, N. J., Li, S., Mostafa, S., Saleh, I., Benza, R., Talreja, D. R., & Summers, M. R. (2026). Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Association With Reduced Ischemic Stroke Risk. Catheterization and Cardiovascular Interventions, 107(6), 2124-2134. https://doi.org/10.1002/ccd.70579
Vancouver
Saleh O, Valle NJ, Li S, Mostafa S, Saleh I, Benza R, et al. Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Association With Reduced Ischemic Stroke Risk. Catheterization and Cardiovascular Interventions. 2026;107(6):2124-2134. doi:10.1002/ccd.70579
BibTeX
@article{Saleh2026,
author = {Saleh, Omar and Valle, Nicholas J and Li, Shinjer and Mostafa, Saleh and Saleh, Israa and Benza, Raymond and Talreja, Deepak R and Summers, Matthew R},
title = {Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Association With Reduced Ischemic Stroke Risk},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {107},
number = {6},
pages = {2124--2134},
doi = {10.1002/ccd.70579}
}
EUVIMED